DCTD Workshop: Translating Emerging Cancer Diagnostics and Technologies toward Clinical Impact
May 5 – May 6, 2026
Virtual
Please join the NCI Division of Cancer Treatment and Diagnosis (DCTD) for a two-day virtual workshop focused on accelerating the translation of emerging cancer diagnostics and enabling technologies into measurable clinical impact. The workshop will convene experts and stakeholders from across DCTD programs and the NCI Small Business Innovation Research (SBIR) program, along with senior investigators, early-stage investigators, and industry leaders, in a solution-oriented forum designed to bridge scientific innovation and real-world clinical implementation.
Workshop objective:
To accelerate translation from discovery to clinical adoption by (i) showcasing next-generation biomarker and enabling technology platforms, (ii) strengthening cross-sector collaboration across academia, industry, and government, (iii) engaging and supporting both senior investigators and early-stage investigators through focused discussion, visibility, and mentorship, and (iv) outlining NCI-supported funding, partnership, and commercialization pathways that advance measurable clinical impact.
Day 1 spotlights foundational innovation in biomarker science. Day 2 focuses on industry perspectives, funding pathways, and awardee case studies to align projects with available NCI funding mechanisms.
More information including the agenda and speaker bios are available on the event site here.
Register now to participate!